MEDICIS PHARMACEUTICAL-CL A (NYSE:MRX), Up By 5.15% ($1.95) From $37.890 After BUYINS.NET Report Predicted Stock Would Go Up Du

July 7, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Tuesday, May 10th 2011 stating that MEDICIS PHARMACEUTICAL-CL A (NYSE:MRX) was expected to go Up due to the Bullish conditions presented in the following report. Click here to view the BUYINS.NET report:

http://www.buyins.net/releases/?sym=mrx&id=165554

At the time this story was written, MEDICIS PHARMACEUTICAL-CL A (NYSE:MRX) is Up By $1.95 (5.15%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at

http://www.squeezetrigger.com/services/strat/mh.php

MEDICIS PHARMACEUTICAL-CL A (NYSE:MRX) - Medicis Pharmaceutical Corporation, a specialty pharmaceutical company, engages in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States, Canada, and Europe. The companys products address various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis, and cosmesis. Its primary products include DYSPORT for temporary improvement in the appearance of glabellar lines in adults younger than 65 years of age; LIPOSONIX to destroy targeted fat just beneath the skin in the treatment of the anterior abdomen; PERLANE and RESTYLANE for the correction of facial wrinkles and folds, such as nasolabial folds; SOLODYN for the treatment of inflammatory lesions of non-nodular acne vulgaris in patients 12 years of age and older; TRIAZ for the topical treatment of acne vulgaris; VANOS, a topical corticosteroid for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older; and ZIANA, a topical treatment of acne vulgaris in patients 12 years of age and older. The company sells its products primarily to wholesale pharmaceutical distributors and retail pharmacy chains. It has strategic collaborations with Glenmark; Revance Therapeutics, Inc.; Hyperion Therapeutics, Inc.; Perrigo Israel Pharmaceuticals Ltd.; and IMPAX Laboratories, Inc. The company was founded in 1987 and is headquartered in Scottsdale, Arizona.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Like: 👍